SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
Abstract:
The present invention relates to Sor CS1-like agents, including Sor CS1, nucleic acid molecule encoding expression of Sor CS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing Sor CS1 and said fragments, for use in the treatment of insulin resistance.
Information query
Patent Agency Ranking
0/0